{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:48:04Z","timestamp":1790300884369,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T00:00:00Z","timestamp":1540166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00228-018-2582-6","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T15:55:59Z","timestamp":1540223759000},"page":"287-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["No alteration of voriconazole concentration by plasmapheresis in a critically ill patient"],"prefix":"10.1007","volume":"75","author":[{"given":"Manuela","family":"Vay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin I.","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazyar","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"See\u00dfle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1783-133X","authenticated-orcid":false,"given":"Gerd","family":"Mikus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,22]]},"reference":[{"issue":"4","key":"2582_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s13054-014-0458-4","volume":"18","author":"M Bassetti","year":"2014","unstructured":"Bassetti M, Righi E, De Pascale G, De Gaudio R, Giarratano A, Mazzei T, Morace G, Petrosillo N, Stefani S, Antonelli M (2014) How to manage aspergillosis in non-neutropenic intensive care unit patients. Crit Care 18(4):458. \n                    https:\/\/doi.org\/10.1186\/s13054-014-0458-4","journal-title":"Crit Care"},{"issue":"4","key":"2582_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE (2016) Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63(4):e1\u2013e60. \n                    https:\/\/doi.org\/10.1093\/cid\/ciw326","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2582_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2165\/00003088-200645070-00002","volume":"45","author":"U Theuretzbacher","year":"2006","unstructured":"Theuretzbacher U, Ihle F, Derendorf H (2006) Pharmacokinetic\/pharmacodynamic profile of voriconazole. Clin Pharmacokinet 45(7):649\u2013663. \n                    https:\/\/doi.org\/10.2165\/00003088-200645070-00002","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"2582_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/cid\/cis437","volume":"55","author":"A Pascual","year":"2012","unstructured":"Pascual A, Csajka C, Buclin T, Bolay S, Bille J, Calandra T, Marchetti O (2012) Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections. Clin Infect Dis 55(3):381\u2013390. \n                    https:\/\/doi.org\/10.1093\/cid\/cis437","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2582_CR5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1592\/phco.27.11.1529","volume":"27","author":"RB Ibrahim","year":"2007","unstructured":"Ibrahim RB, Liu C, Cronin SM, Murphy BC, Cha R, Swerdlow P, Edwards DJ (2007) Drug removal by plasmapheresis: an evidence-based review. Pharmacotherapy 27(11):1529\u20131549. \n                    https:\/\/doi.org\/10.1592\/phco.27.11.1529","journal-title":"Pharmacotherapy"},{"issue":"4","key":"2582_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/jca.10074","volume":"18","author":"PE Kintzel","year":"2003","unstructured":"Kintzel PE, Eastlund T, Calis KA (2003) Extracorporeal removal of antimicrobials during plasmapheresis. J Clin Apher 18(4):194\u2013205. \n                    https:\/\/doi.org\/10.1002\/jca.10074","journal-title":"J Clin Apher"},{"issue":"1","key":"2582_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/FTD.0b013e31827d76b0","volume":"35","author":"I Spriet","year":"2013","unstructured":"Spriet I, Bruggemann RJ, Annaert P, Meersseman P, Van Wijngaerden E, Lagrou K, Willems L (2013) Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange. Ther Drug Monit 35(1):141\u2013143. \n                    https:\/\/doi.org\/10.1097\/FTD.0b013e31827d76b0","journal-title":"Ther Drug Monit"},{"key":"2582_CR8","unstructured":"Pfizer Vfend: Summary of product characteristics. state of information: January 2017 \n                    https:\/\/www.fachinfo.de\/pdf\/015292\n                    \n                   (accessed 08\/2018)"},{"issue":"8","key":"2582_CR9","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/jps.24064","volume":"103","author":"K Vanstraelen","year":"2014","unstructured":"Vanstraelen K, Wauters J, De Loor H, Vercammen I, Annaert P, Lagrou K, Spriet I (2014) Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis. J Pharm Sci 103(8):2565\u20132570. \n                    https:\/\/doi.org\/10.1002\/jps.24064","journal-title":"J Pharm Sci"},{"key":"2582_CR10","unstructured":"Preston C Stockley\u2019s drug interactions [online]. In: ed Pharmaceutical Press \n                    www.medicinescomplete.com\n                    \n                   (accessed 08\/2018)"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2582-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T20:39:42Z","timestamp":1571690382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2582-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,22]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2582"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2582-6","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,22]]},"assertion":[{"value":"31 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent of the patient was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent of the patient"}}]}}